Algorithm-based modular psychotherapy vs. cognitive-behavioral therapy for patients with depression, psychiatric comorbidities and early trauma: a proof-of-concept randomized controlled trial.

Depression algorithm‐based modular psychotherapy cognitive‐behavioral therapy early trauma empathy mechanism‐based treatment social processes transdiagnostic treatment modules trauma‐related mechanisms

Journal

World psychiatry : official journal of the World Psychiatric Association (WPA)
ISSN: 1723-8617
Titre abrégé: World Psychiatry
Pays: Italy
ID NLM: 101189643

Informations de publication

Date de publication:
Jun 2024
Historique:
medline: 10 5 2024
pubmed: 10 5 2024
entrez: 10 5 2024
Statut: ppublish

Résumé

Effect sizes of psychotherapies currently stagnate at a low-to-moderate level. Personalizing psychotherapy by algorithm-based modular procedures promises improved outcomes, greater flexibility, and a better fit between research and practice. However, evidence for the feasibility and efficacy of modular-based psychotherapy, using a personalized treatment algorithm, is lacking. This proof-of-concept randomized controlled trial was conducted in 70 adult outpatients with a primary DSM-5 diagnosis of major depressive disorder, a score higher than 18 on the 24-item Hamilton Rating Scale for Depression (HRSD-24), at least one comorbid psychiatric diagnosis according to the Structured Clinical Interview for DSM-5 (SCID-5), a history of at least "moderate to severe" childhood maltreatment on at least one domain of the Childhood Trauma Questionnaire (CTQ), and exceeding the cut-off value on at least one of three measures of early trauma-related transdiagnostic mechanisms: the Rejection Sensitivity Questionnaire (RSQ), the Interpersonal Reactivity Index (IRI), and the Difficulties in Emotion Regulation Scale-16 (DERS-16). Patients were randomized to 20 sessions of either standard cognitive-behavioral therapy alone (CBT) or CBT plus transdiagnostic modules according to a mechanism-based treatment algorithm (MoBa), over 16 weeks. We aimed to assess the feasibility of MoBa, and to compare MoBa vs. CBT with respect to participants' and therapists' overall satisfaction and ratings of therapeutic alliance (using the Working Alliance Inventory - Short Revised, WAI-SR), efficacy, impact on early trauma-related transdiagnostic mechanisms, and safety. The primary outcome for efficacy was the HRSD-24 score at post-treatment. Secondary outcomes included, among others, the rate of response (defined as a reduction of the HRSD-24 score by at least 50% from baseline and a score <16 at post-treatment), the rate of remission (defined as a HRSD-24 score ≤8 at post-treatment), and improvements in early trauma-related mechanisms of social threat response, hyperarousal, and social processes/empathy. We found no difficulties in the selection of the transdiagnostic modules in the individual patients, applying the above-mentioned cut-offs, and in the implementation of MoBa. Both participants and therapists reported higher overall satisfaction and had higher WAI-SR ratings with MoBa than CBT. Both approaches led to major reductions of depressive symptoms at post-treatment, with a non-significant superiority of MoBa over CBT. Patients randomized to MoBa were nearly three times as likely to experience remission at the end of therapy (29.4% vs. 11.4%; odds ratio, OR = 3.2, 95% CI: 0.9-11.6). Among mechanism-based outcomes, MoBa patients showed a significantly higher post-treatment effect on social processes/empathy (p<0.05) compared to CBT patients, who presented an exacerbation on this domain at post-treatment. Substantially less adverse events were reported for MoBa compared to CBT. These results suggest the feasibility and acceptability of an algorithm-based modular psychotherapy complementing CBT in depressed patients with psychiatric comorbidities and early trauma. While initial evidence of efficacy was observed, potential clinical advantages and interindividual heterogeneity in treatment outcomes will have to be investigated in fully powered confirmation trials.

Identifiants

pubmed: 38727062
doi: 10.1002/wps.21204
doi:

Types de publication

Journal Article

Langues

eng

Pagination

257-266

Informations de copyright

© 2024 World Psychiatric Association.

Références

Cuijpers P, Karyotaki E, Ciharova M et al. The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: a meta‐analysis. Acta Psychiatr Scand 2021;144:288‐99.
McIntyre RS, Alsuwaidan M, Baune BT et al. Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry 2023;22:394‐412.
Leichsenring F, Steinert C, Rabung S et al. The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses. World Psychiatry 2022;21:133‐45.
Purgato M, Singh R, Acarturk C et al. Moving beyond a ‘one‐size‐fits‐all’ rationale in global mental health: prospects of a precision psychology paradigm. Epidemiol Psychiatr Sci 2021;30:e63.
Huibers MJH, Lorenzo‐Luaces L, Cuijpers P et al. On the road to personalized psychotherapy: a research agenda based on cognitive behavior therapy for depression. Front Psychiatry 2021;11:607508.
Schramm E, Rapee R, Furukawa TA. Time for a paradigm shift for psychotherapies? Evid Based Ment Health 2021;24:1.
Chorpita BF, Daleiden EL, Weisz JR. Modularity in the design and application of therapeutic interventions. Appl Prevent Psychol 2005;11:141‐56.
Bohus M, Herpertz SC, Falkai P. Modulare Psychotherapie – Rationale und Grundprinzipien. Die Psychiatrie 2012;9:89‐97.
Cohen ZD, Delgadillo J, DeRubeis RJ. Personalized treatment approaches. In: Barkham M, Lutz W, Castonguay LG (eds). Bergin and Garfield's handbook of psychotherapy and behavior change, 7th ed. Hoboken: Wiley, 2021:673‐703.
Herpertz SC, Schramm E. Modulare Psychotherapie: ein Mechanismus‐basiertes, personalisiertes Vorgehen. Stuttgart: Schattauer, 2022.
Cheron DM, Becker‐Haimes EM, Stern HG et al. Assessing practical implementation of modular psychotherapy for youth in community‐based settings using benchmarking. Implement Res Pract 2022;3:26334895221115216.
Venturo‐Conerly KE, Reynolds R, Clark M et al. Personalizing youth psychotherapy: a scoping review of decision‐making in modular treatments. Clin Psychol Sci Pract 2023;30:45‐62.
Black M, Hitchcock C, Bevan A et al. The HARMONIC trial: study protocol for a randomised controlled feasibility trial of Shaping Healthy Minds – a modular transdiagnostic intervention for mood, stressor‐related and anxiety disorders in adults. BMJ Open 2018;8:e024546.
Black M, Johnston D, Elliott R et al. A randomised controlled feasibility trial (the HARMONIC Trial) of a novel modular transdiagnostic intervention – Shaping Healthy Minds – versus psychological treatment‐as‐usual, for clinic‐attending adults with comorbid mood, stressor‐related and anxiety disorders. PsyArXiv 2023;10.31234/osf.io/7muz5.
Herpertz SC, Matzke B, Hillmann K et al. A mechanism‐based group‐psychotherapy approach to aggressive behaviour in borderline personality disorder: findings from a cluster‐randomised controlled trial. BJPsych Open 2020;7:e17.
Wilhelm S, Phillips KA, Didie E et al. Modular cognitive‐behavioral therapy for body dysmorphic disorder: a randomized controlled trial. Behav Ther 2014;45:314‐27.
Karatzias T, Mc Glanaghy E, Cloitre M. Enhanced Skills Training in Affective and Interpersonal Regulation (ESTAIR): a new modular treatment for ICD‐11 complex posttraumatic stress disorder (CPTSD). Brain Sci 2023;13:1300.
Wen A, Wolitzky‐Taylor K, Gibbons RD et al. A randomized controlled trial on using predictive algorithm to adapt level of psychological care for community college students: STAND triaging and adapting to level of care study protocol. Trials 2023;24:508.
Wolitzky‐Taylor K, LeBeau R, Arnaudova I et al. A novel and integrated digitally supported system of care for depression and anxiety: findings from an open trial. JMIR Ment Health 2023;10:e46200.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56‐62.
US National Institute of Mental Health. Research Domain Criteria (RDoC). www.nimh.nih.gov.
Schnell K, Herpertz SC. Emotion regulation and social cognition as functional targets of mechanism‐based psychotherapy in major depression with comorbid personality pathology. J Pers Disord 2018;32(Suppl.):12‐35.
Teicher MH, Samson JA, Anderson CM et al. The effects of childhood maltreatment on brain structure, function and connectivity. Nat Rev Neurosci 2016;17:652‐66.
Rokita KI, Dauvermann MR, Donohoe G. Early life experiences and social cognition in major psychiatric disorders: a systematic review. Eur Psychiatry 2018;53:123‐33.
First MB, Williams JBW, Karg RS et al. Structured Clinical Interview for DSM‐5 – research version. Arlington: American Psychiatric Association, 2015.
Bernstein DP, Stein JA, Newcomb MD et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Neglect 2003;27:169‐90.
Sloan E, Hall K, Moulding R et al. Emotion regulation as a transdiagnostic treatment construct across anxiety, depression, substance, eating and borderline personality disorders: a systematic review. Clin Psychol Rev 2017;57:141‐63.
Downey G, Feldman SI. Implications of rejection sensitivity for intimate relationships. J Pers Soc Psychol 1996;70:1327‐43.
Davis MH. Measuring individual differences in empathy: evidence for a multidimensional approach. J Pers Soc Psychol 1983;44:113‐26.
Bjureberg J, Ljótsson B, Tull MT et al. Development and validation of a brief version of the Difficulties in Emotion Regulation Scale: the DERS‐16. J Psychopathol Behav Assess 2016;38:284‐96.
First MB, Williams JBW, Benjamin LS et al. User's guide for the SCID‐5‐PD (Structured Clinical Interview for DSM‐5 Personality Disorders). Arlington: American Psychiatric Association, 2015.
Elsaesser M, Herpertz S, Piosczyk H et al. Modular‐based psychotherapy (MoBa) versus cognitive‐behavioural therapy (CBT) for patients with depression, comorbidities and a history of childhood maltreatment: study protocol for a randomised controlled feasibility trial. BMJ Open 2022;12:e057672.
Hautzinger M. Kognitive Verhaltenstherapie bei Depressionen. 7. Auflage. Weinheim: Beltz Psychologie Verlags Union, 2013.
McCullough JP. Treatment for chronic depression. Cognitive behavioral analysis system of psychotherapy. New York: Guilford, 2000.
McCullough JP, Penberthy J, Schramm E et al. CBASP as a distinctive treatment for persistent depressive disorder. London: Routledge, 2014.
Bateman AW, Fonagy P. Handbook of mentalizing in mental health practice. Washington: American Psychiatric Publishing, 2019.
Williams JMG, Crane C, Barnhofer T et al. Mindfulness‐based cognitive therapy for preventing relapse in recurrent depression: a randomized dismantling trial. J Consult Clin Psychol 2014;82:275‐86.
Hatcher RL, Gillaspy JA. Development and validation of a revised short version of the Working Alliance Inventory. Psychother Res 2006;16:12‐25.
Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory‐II. San Antonio: Psychological Corporation, 1996.
Beck AT, Steer RA. Beck Anxiety Inventory manual. San Antonio: Psychological Corporation, 1993.
Goldman HH, Skodol AE, Lave TR. Revising axis V for DSM‐IV: a review of measures of social functioning. Am J Psychiatry 1992;149:1148‐56.
The WHOQOL Group. Development of the World Health Organization WHOQOL‐BREF Quality of Life Assessment. Psychol Med 1998;28:551‐8.
Meister R, Lanio J, Fangmeier T et al. Adverse events during a disorder‐specific psychotherapy compared to a nonspecific psychotherapy in patients with chronic depression. J Clin Psychol 2020;76:7‐19.
Billingham SAM, Whithead A, Julious SA. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database. BMC Med Res Methodol 2013;13:104.
Kramer U, Eubanks CF, Bertsch K et al. Future challenges in psychotherapy research for personality disorders. Curr Psychiatry Rep 2022;24:613‐22.
Fried EI, Nesse RM. Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR*D study. J Affect Disord 2015;172:96‐102.
Goerigk S, Reinhard MA, Barton BB et al. Transdiagnostic analysis of adverse childhood experiences and their association with psychopathology – a TRANS‐D conform study. Psychiatry Res 2023;329:115545.
Elsaesser M, Feige B, Kriston L et al. Longitudinal clusters of long‐term trajectories in patients with early‐onset chronic depression: 2 years of naturalistic follow‐up after extensive psychological treatment. Psychother Psychosom 2023; doi: 10.1159/000535005.
Kaiser T, Volkmann C, Volkmann A et al. Heterogeneity of treatment effects in trials on psychotherapy of depression. Clin Psychol Sci Pract 2022;29:294‐303.
Solomonov N, Barber JP. Unpacking the heterogeneity in treatment effects as a path to personalized psychotherapies: are we there yet? Clin Psychol Sci Pract 2022;29:308‐10.
Furukawa TA, Efthimiou O, Weitz ES et al. Cognitive‐behavioral analysis system of psychotherapy, drug, or their combination for persistent depressive disorder: personalizing the treatment choice using individual participant data network metaregression. Psychother Psychosom 2018;87:140‐53.
Cuijpers P, Miguel C, Harrer M et al. Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta‐analysis including 409 trials with 52,702 patients. World Psychiatry 2023;22:105‐15.
Lutz W, Rubel J, Deisenhofer AK et al. Continuous outcome measurement in modern data‐informed psychotherapies. World Psychiatry 2022;21:215‐6.
Barkham M, De Jong K, Delgadillo J et al. Routine outcome monitoring (ROM) and feedback: research review and recommendations. Psychother Res 2023;33:841‐55.
Baldwin SA, Goldberg SB. Methodological foundations and innovations in quantitative psychotherapy research. In: Barkham M, Lutz W, Castonguay LG (eds). Bergin and Garfield's handbook of psychotherapy and behavior change, 7th ed. Hoboken: Wiley, 2021:19‐50.
Shadish WR, Cook TD, Campbell DT. Experimental and quasi‐experimental designs for generalized causal inference. Boston: Houghton, Mifflin & Co., 2002.
Stumpp NE, Sauer‐Zavala S. Evidence‐based strategies for treatment personalization: a review. Cogn Behav Pract 2022;29:902‐13.
Schottenbauer MA, Glass CR, Arnkoff DB. Decision making and psychotherapy integration: theoretical considerations, preliminary data, and implications for future research. J Psychother Integration 2007;17:225‐50.

Auteurs

Elisabeth Schramm (E)

Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Moritz Elsaesser (M)

Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Carolin Jenkner (C)

Clinical Trials Unit, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Martin Hautzinger (M)

Department of Psychology, Clinical Psychology, and Psychotherapy, Eberhard Karls University of Tübingen, Tübingen, Germany.

Sabine C Herpertz (SC)

Department of General Psychiatry, Center for Psychosocial Medicine, Medical Faculty, Heidelberg University, Heidelberg, Germany.
German Center for Mental Health (DZPG), partner site Mannheim/Heidelberg/Ulm, Germany.

Classifications MeSH